These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 688880)

  • 1. [Myasthenia gravis and LE nephritis: problems of treatment with cholinesterase inhibitors during long-term dialysis (author's transl)].
    Korz R; Klein H; Genth E
    Dtsch Med Wochenschr; 1978 Sep; 103(38):1485-8. PubMed ID: 688880
    [No Abstract]   [Full Text] [Related]  

  • 2. End-stage renal failure in systemic lupus erythematosus with nephritis.
    Correia P; Cameron JS; Ogg CS; Williams DG; Bewick M; Hicks JA
    Clin Nephrol; 1984 Dec; 22(6):293-302. PubMed ID: 6396007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical therapy for oropharyngeal symptoms of myasthenia gravis.
    Dooley JM; Goulden KJ; Gatien JG; Gibson EJ; Brown BS
    Ann Neurol; 1986 Feb; 19(2):192-4. PubMed ID: 3963762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dialysis and transplantation in end-stage lupus nephritis.
    Ziff M; Helderman JH
    N Engl J Med; 1983 Jan; 308(4):218-9. PubMed ID: 6336826
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapy of myasthenia (author's transl)].
    Birnberger KL; Struppler A
    MMW Munch Med Wochenschr; 1976 Dec; 118(51):1653-6. PubMed ID: 187931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Myasthenia gravis and visceral lupus erythematosus].
    Truniger B
    Schweiz Med Wochenschr; 1979 Dec; 109(47):1847-51. PubMed ID: 394318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dialysis treatment of renal failure in patients with SLE--the results of nationwide survey in Japan (author's transl)].
    Nagasawa T; Yoshida M; Koyama N
    Nihon Jinzo Gakkai Shi; 1978 Nov; 20(11):1141-7. PubMed ID: 748638
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hemodialysis in lupus nephritis--analysis of six cases (author's transl)].
    Ozaki S; Kumagai S; Kotani H; Tsunematsu T; Imura H; Tamura T; Hara A; Konishi N; Sawanishi K
    Nihon Naika Gakkai Zasshi; 1978 Jul; 67(7):729-38. PubMed ID: 701932
    [No Abstract]   [Full Text] [Related]  

  • 9. Myasthenia gravis associated with lupus nephritis.
    Lee H; Chen W; Su K; Chou C; Tsai C
    Lupus; 2008 Sep; 17(9):860-1. PubMed ID: 18755870
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pyridostigmine mixture in the treatment of myasthenia gravis].
    Behrens JK
    Ugeskr Laeger; 1992 Feb; 154(8):508. PubMed ID: 1539384
    [No Abstract]   [Full Text] [Related]  

  • 11. Successful desensitization protocol for pyridostigmine hypersensitivity in a patient with myasthenia gravis.
    Aung T; Dowden AY
    Ann Allergy Asthma Immunol; 2013 Apr; 110(4):308. PubMed ID: 23535103
    [No Abstract]   [Full Text] [Related]  

  • 12. "End-stage" lupus nephritis: clinical course to and outcome on dialysis. Experience with 39 patients.
    Kimberly RP; Lockshin MD; Sherman RL; Beary JF; Mouradian J; Cheigh JS
    Medicine (Baltimore); 1981 Jul; 60(4):277-87. PubMed ID: 7242321
    [No Abstract]   [Full Text] [Related]  

  • 13. [Systemic lupus erythematosus and end-stage chronic renal insufficiency. Therapeutic perspectives].
    Font J; Campistol JM
    Med Clin (Barc); 1989 Apr; 92(15):573-6. PubMed ID: 2666771
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of myasthenia gravis].
    Janda A; Brandstetter A
    Dtsch Med Wochenschr; 1986 Jul; 111(27):1081-2. PubMed ID: 3720565
    [No Abstract]   [Full Text] [Related]  

  • 15. Myasthenia gravis and scleroderma.
    Bhalla R; Swedler WI; Lazarevic MB; Ajmani HS; Skosey JL
    J Rheumatol; 1993 Aug; 20(8):1409-10. PubMed ID: 8230029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overlooked myasthenia gravis in an elderly adult.
    Jiang L; Wu W; Guan W; Wu Z; Nie Y
    J Am Geriatr Soc; 2013 May; 61(5):840-1. PubMed ID: 23672558
    [No Abstract]   [Full Text] [Related]  

  • 17. [Plasma exchange in progressive lupus nephritis].
    Hörmann A; Keusch G; Burger R; Briner J; Binswanger U; Gmür J
    Schweiz Med Wochenschr; 1982 Jun; 112(24):853-8. PubMed ID: 7112055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnosis and treatment of ocular myasthenia (author's transl)].
    Huber A
    Klin Monbl Augenheilkd; 1977 Dec; 171(6):889-95. PubMed ID: 203742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myasthenia gravis, systemic lupus erythematosus and urticaria. (Case 1). Myasthenia gravis and herpetiform acantholysis. (Case 2).
    Darley CR; Munro DD; Borrie PF
    Proc R Soc Med; 1977 Oct; 70(10):734-7. PubMed ID: 928387
    [No Abstract]   [Full Text] [Related]  

  • 20. A cause of reversible dysphagia: an unusual presentation of myasthenia gravis.
    Brostoff JM; Dahdaleh D; Birns J
    Eur J Intern Med; 2008 Jan; 19(1):70. PubMed ID: 18206608
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.